July 7, 2022 by Chain Drug Review
Biden administration, JC Scott, PCMA
Leading Headlines, Pharmacy
WASHINGTON — Pharmaceutical Care Management Association (PCMA) president and CEO JC Scott issued the following statement on the Biden Administration’s announcement to curb drug manufacturer patent abuses. “We applaud the Biden Administration for taking real action to reduce prescription drug costs. Drug manufacturer pricing strategies that include patent thickets on certain brand drugs unfairly protect
January 25, 2022 by Chain Drug Review
JC Scott, Pharmaceutical Care Management Association (PCMA)
Leading Headlines, Pharmacy
WASHINGTON — Pharmaceutical Care Management Association President and CEO JC Scott issued the following statement on a new report by the U.S. Health and Human Services Assistant Secretary for Planning and Evaluation (ASPE), Office of Health Policy, showing that minorities in Medicare are the most likely to experience prescription drug affordability problems. “The Administration’s research on
July 13, 2021 by Chain Drug Review
JC Scott, The Pharmaceutical Care Management Association (PCMA)
Leading Headlines, Pharmacy
WASHINGTON — The Pharmaceutical Care Management Association (PCMA) announced on Tuesday a set of industry principles that outline how pharmacy benefit managers, PBMs, interact with employer clients and other prescription drug coverage sponsors to provide clear, transparent contracting and deliver affordable pharmacy benefits. “These principles reinforce the industry’s commitment to PBM interactions that empower employers and
April 15, 2021 by Chain Drug Review
and the Pharmaceutical Care Management Association (PCMA), JC Scott
Leading Headlines, Pharmacy
WASHINGTON — Pharmaceutical Care Management Association President and CEO JC Scott issued the following statement on legislation passed by Congress to increase access to biosimilars, “The Ensuring Innovation Act” and the “Advancing Education on Biosimilars Act of 2021.” “We applaud Congress for recognizing the need to increase competition in the prescription drug marketplace, especially for
November 9, 2020 by Chain Drug Review
2020 Presidential election, JC Scott, PCMA
Leading Headlines, Pharmacy
WASHINGTON — PCMA president and CEO JC Scott issued the following statement on the 2020 presidential election: “The Pharmaceutical Care Management Association, representing America’s pharmacy benefit managers (PBMs) congratulates the President-elect and looks forward to working with the new Administration on lowering prescription drug costs for all Americans. “We appreciate the stated focus of the
September 30, 2020 by Chain Drug Review
JC Scott, PBMs, Pharmaceutical Care Management Association
Leading Headlines, Pharmacy
WASHINGTON — Pharmaceutical Care Management Association president and CEO JC Scott issued the following statement on today’s hearing in the House Committee on Oversight and Reform on pricing practices for prescription drugs: “We appreciate the House Oversight Committee keeping a spotlight on drug manufacturers’ pricing practices. While drug manufacturers are solely responsible for setting and
August 27, 2020 by Chain Drug Review
JC Scott, PCMA
Leading Headlines, Pharmacy
WASHINGTON — Pharmaceutical Care Management Association (PCMA) president and CEO JC Scott issued the following statement on the reported “counteroffer” by the pharma lobby to the Administration: “While we remain deeply engaged in seeking solutions to lower drug prices and are as eager as anyone to see more progress, as reported, the ‘counteroffer’ that has
August 3, 2020 by Chain Drug Review
Administration’s plans to revive the so-called rebate rule, JC Scott, The Pharmaceutical Care Management Association (PCMA)
Leading Headlines, Pharmacy
WASHINGTON — The Pharmaceutical Care Management Association (PCMA) is announcing the launch of the next series of ads as part of the TV and digital advertising campaign on the Administration’s plans to revive the so-called rebate rule. View the new TV ad. “President Trump made the right decision last year to protect America’s seniors by withdrawing
May 8, 2020 by Chain Drug Review
HB 978/SB 915, JC Scott, Pharmaceutical Care Management Association (PCMA)
Leading Headlines, Pharmacy
WASHINGTON — The Pharmaceutical Care Management Association (PCMA) issued on Friday the following statement applauding the Maryland legislature and Governor Larry Hogan for enacting first-of-its-kind legislation, HB 978/SB 915, to increase transparency in the prescription drug supply chain. The legislation, sponsored by Delegate Ariana Kelly and Senator Benjamin Kramer, will give Maryland policymakers and the
March 27, 2020 by Chain Drug Review
COVID-19, JC Scott, PCMA
Leading Headlines, Pharmacy
WASHINGTON — On Thursday, members of the prescription drug supply and payment chain, including pharmacy benefit managers (PBMs), pharmaceutical manufacturers, pharmacies, including specialty and managed care pharmacies, and health plans, sent a letter to Vice President Mike Pence and congressional leaders affirming the safety and resiliency of the drug supply chain, and calling for public-private
March 25, 2020 by Chain Drug Review
JC Scott, Pharmaceutical Care Management Association (PCMA), Rutledge versus PCMA
Leading Headlines, Pharmacy
WASHINGTON — On Wednesday, the Pharmaceutical Care Management Association (PCMA) filed its brief with the U.S. Supreme Court in the case of Rutledge versus PCMA, arguing that a misguided Arkansas law creates inefficiencies in employer-sponsored health plans and threatens access to prescription drugs. The brief comes in advance of anticipated oral arguments next month. Unique state
March 11, 2020 by Chain Drug Review
JC Scott, PCMA, Pharmaceutical Care Management Association (PCMA), Regina Stivers
Leading Headlines, Pharmacy
WASHINGTON — The Pharmaceutical Care Management Association (PCMA) has announced that Regina Stivers as PCMA’s newest staff addition. Stivers joins PCMA as director, state affairs. She brings a tremendous amount of experience, having worked in both federal and state government and in the private sector overseeing economic development. Before joining PCMA, Regina served as both
February 26, 2020 by Chain Drug Review
JC Scott, PBMs, PCMA
Leading Headlines, Pharmacy
WASHINGTON — Pharmacy benefit managers (PBMs) save consumers and payers an average of $962 per person per year, according to a new analysis by Visante, a $21 increase from 2016. The research also highlights PBMs’ role in reducing medication errors and improving patients’ health through increased adherence rates and specialty pharmacies. “As prescription drug prices
February 19, 2020 by Chain Drug Review
JC Scott, Pharmaceutical Care Management Association (PCMA)
Leading Headlines, Pharmacy
WASHINGTON — As prescription drug spending is poised to reach as much as $5 trillion during the next decade, new data find that pharmacy benefit managers’ (PBMs’) proven cost savings and patient care management tools should reduce prescription drug costs for health plan sponsors and consumers by an average of 20%, or more than $1